Do Traders Think Longeveron Inc (LGVN) Can Keep Climbing Thursday?

Overall market sentiment has been down on Longeveron Inc (LGVN) stock lately. LGVN receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Longeveron Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on LGVN!

See Full LGVN Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With LGVN Stock Today?

Longeveron Inc (LGVN) stock is trading at $3.19 as of 10:03 AM on Thursday, Aug 31, an increase of $0.75, or 30.61% from the previous closing price of $2.44. The stock has traded between $2.75 and $3.30 so far today. Volume today is high. So far 314,008 shares have traded compared to average volume of 29,100 shares. To see InvestorsObserver's Sentiment Score for Longeveron Inc click here.

More About Longeveron Inc

Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Hypoplastic left heart syndrome (HLHS). Click Here to get the full Stock Report for Longeveron Inc stock.